Authors
Latest:
General Availability for .Pharmacy Domain Names Begins June 3, 2015The National Association of Boards of Pharmacy® (NABP®) is pleased to announce that general availability for the .pharmacy domain begins June 3, 2015.
Latest:
Persistence With Mirabegron Versus Tolterodine in Patients With Overactive BladderIn a retrospective analysis of the Optum database, overactive bladder patients treated with mirabegron bladder patients persisted longer with treatment than patients treated with tolterodine, and had reduced resource utilization and costs.
Latest:
Psoriasis Treatment Patterns: Phototherapy, Oral Nonbiologic, and Biologic TherapiesAmong psoriasis patients initiated on oral nonbiologic or on biologic therapy, most patients undergo at least 1 therapy change within 4 months of treatment initiation.
Latest:
Utility of Antithrombotic Therapy in Chronic Systolic Heart FailureThe primary care physician for a 67-year-old female patient with hypertension, dyslipidemia, and chronic non-ischemic systolic heart failure wants to know whether to initiate an antithrombotic agent.
Latest:
Supply Chain InnovationsComplex distribution challenges for manufacturers of specialty drugs require life science and cold chain experts to provide a faster, better way of distributing these life-saving medications.
Latest:
Impact of Co-Payment Discounts on Antidepressant Medication Adherence and CostsA unique co-payment discount program for antidepressants was associated with higher antidepressant medication adherence, lower likelihood of discontinuation, and lower healthcare costs.
Latest:
Self-Reported Plan Switching in Medicare Part D: 2006-2010Less than one-fourth of Part D beneficiaries reported switching plans. Elderly beneficiaries who reported switching did not realize significant savings in prescription costs over nonswitchers.
Latest:
Psoriasis Treatment Cost Comparison: Biologics Versus Home PhototherapyAn estimation and comparison of the cost of home phototherapy versus biologics over a 3-year time horizon in patients with moderate-to-severe plaque psoriasis.
Latest:
Resource Use Among Nonvalvular Atrial Fibrillation PatientsThis study assesses comparative resource use for patients given a new diagnosis of nonvalvular atrial fibrillation treated with dabigatran or warfarin in a real-world setting.
Latest:
Clinicians, Pharmacists Should Work to Ensure Safety Compounded GLP-1 MedicationsPharmacists can educate patients about how to recognize unsafe online sources of medications and ensure patients are properly educate on how to administer their medications.
Latest:
Not Just a Generic: Specialty Pharmacy Considerations for a Biosimilar LaunchAs new biosimilars enter the market, pharmacies should carefully consider infrastructure, resources, and strategies for successfully integrating the products into their portfolio of offerings.
Latest:
Ten Years of Telemedicine- Based Prescribing Leads to LawsuitPharmacy and physician were defendants.
Latest:
Why Some Supplements Are Fraudulent and HarmfulThe FDA is not authorized to review the safety and efficacy of dietary supplement products before they are sold on the market.
Latest:
Standard of Care: The No. 1 Priority to Ensure Success in Pharmacy Practice’s FutureSOC emphasizes adaptability and individual professional judgment without compromising quality, as individuals are held to the standard and expertise of their practice area.
Latest:
Community Health Centers: A Pharmacist's PerspectiveBy focusing on primary healthcare, community health centers keep down healthcare costs for all consumers, taxpayers, and governments.
Latest:
Applying Value-Based Incentive Models Within Community Pharmacy PracticeHealthcare is transforming through new payment models, including value-based incentives (VBIs); this article discusses implementation principles and operational strategies for VBIs in community pharmacy practice.
Latest:
Applying Value-Based Incentive Models Within Community Pharmacy PracticeHealthcare is transforming through new payment models, including value-based incentives (VBIs); this article discusses implementation principles and operational strategies for VBIs in community pharmacy practice.
Latest:
Generic Biologic Drugs Appear Equivalent to Brand Name CounterpartA recent analysis from Johns Hopkins University Bloomberg School of Public Health researchers found that generic forms of the biologic drug infliximab (remicade) appear to be just as safe and effective as the brand name version.
Latest:
Clinical Insights: Zolgensma for Spinal Muscular AtrophyZolgensma is the first gene therapy indicated for the treatment of children with spinal muscular atrophy.
Latest:
Pursuing Specialty Pharmacy AccreditationSelecting an accreditation agency should be determined by the local business environment and needs.
Latest:
Therapeutic Substitution From Atorvastatin to Simvastatin: Impact on LDL ControlEvaluation of a therapeutic substitution from atorvastatin to simvastatin on low-density lipoprotein control, and assessment of program participation rates for a commercially insured population.
